John S. Albin

1.1k total citations
21 papers, 830 citations indexed

About

John S. Albin is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, John S. Albin has authored 21 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 12 papers in Virology and 7 papers in Molecular Biology. Recurrent topics in John S. Albin's work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (9 papers) and Immune Cell Function and Interaction (5 papers). John S. Albin is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (9 papers) and Immune Cell Function and Interaction (5 papers). John S. Albin collaborates with scholars based in United States and Ireland. John S. Albin's co-authors include Reuben S. Harris, Keisuke Shindo, William L. Brown, Mark D. Stenglein, Eric W. Refsland, Guylaine Haché, Hiroshi Matsuo, Judd F. Hultquist, Elena Harjes and Brett D. Anderson and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

John S. Albin

18 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John S. Albin United States 12 594 364 333 252 237 21 830
Mark T. Liddament United States 6 711 1.2× 401 1.1× 435 1.3× 385 1.5× 298 1.3× 6 1.1k
Phuong Thi Nguyen Sarkis United States 14 619 1.0× 302 0.8× 342 1.0× 315 1.3× 430 1.8× 16 984
Matthieu Bertrand France 5 469 0.8× 195 0.5× 265 0.8× 224 0.9× 372 1.6× 6 762
Mariana Santa‐Marta Portugal 9 407 0.7× 237 0.7× 257 0.8× 158 0.6× 189 0.8× 12 615
April J. Schumacher United States 8 474 0.8× 273 0.8× 339 1.0× 387 1.5× 195 0.8× 10 827
Eric C. Logue United States 10 658 1.1× 279 0.8× 406 1.2× 286 1.1× 497 2.1× 10 1.1k
James D. Roser United States 11 595 1.0× 294 0.8× 326 1.0× 202 0.8× 328 1.4× 13 904
Elina Erikson Germany 8 556 0.9× 194 0.5× 278 0.8× 234 0.9× 537 2.3× 10 898
Joy Lengyel United States 7 363 0.6× 172 0.5× 338 1.0× 346 1.4× 197 0.8× 8 745
Loïc Dragin France 5 519 0.9× 207 0.6× 247 0.7× 196 0.8× 391 1.6× 6 746

Countries citing papers authored by John S. Albin

Since Specialization
Citations

This map shows the geographic impact of John S. Albin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Albin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Albin more than expected).

Fields of papers citing papers by John S. Albin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Albin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Albin. The network helps show where John S. Albin may publish in the future.

Co-authorship network of co-authors of John S. Albin

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Albin. A scholar is included among the top collaborators of John S. Albin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Albin. John S. Albin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Albin, John S., et al.. (2025). Rapid generation of hypervariable chemical libraries. Chem. 11(8). 102501–102501.
3.
Hurtado, Rocio, et al.. (2025). Bedaquiline for the Treatment of Pulmonary Non-tuberculous Mycobacterial Infections: Retrospective Analysis From a Large Healthcare System. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A7283–A7283.
4.
Wang, Kwo-Kwang A., et al.. (2024). Class IIb Microcin MccM Interferes with Oxidative Phosphorylation in Escherichia coli. ACS Chemical Biology. 19(9). 1953–1962. 3 indexed citations
5.
Lazarus, Jacob E., Dustin McEvoy, Caitlin M. Dugdale, et al.. (2024). Separating the rash from the chaff: novel clinical decision support deployed during the mpox outbreak. Infection Control and Hospital Epidemiology. 45(8). 1006–1008. 1 indexed citations
6.
Albin, John S., Jacob E. Lazarus, Caitlin M. Dugdale, et al.. (2022). Development and implementation of a clinical decision support system tool for the evaluation of suspected monkeypox infection. Journal of the American Medical Informatics Association. 29(12). 2124–2127. 7 indexed citations
7.
Queen, Jessica, Sara M. Karaba, John S. Albin, et al.. (2021). The Time is Now: A Call for Renewed Support of Infectious Diseases Physician-Scientist Trainees in the Era of Coronavirus Disease 2019. The Journal of Infectious Diseases. 224(9). 1452–1454. 1 indexed citations
8.
Mohareb, Amir M., Jacob M. Rosenberg, Roby P. Bhattacharyya, et al.. (2021). Preventing Infectious Complications of Immunomodulation in COVID-19 in Foreign-Born Patients. Journal of Immigrant and Minority Health. 23(6). 1343–1347. 5 indexed citations
9.
Albin, John S. & Bradley L. Pentelute. (2020). Efficient Flow Synthesis of Human Antimicrobial Peptides*. Australian Journal of Chemistry. 73(4). 380–388. 7 indexed citations
10.
Ikeda, Terumasa, et al.. (2018). HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G. PLoS Pathogens. 14(4). e1007010–e1007010. 31 indexed citations
11.
Richards, Christopher M., John S. Albin, Özlem Demir, et al.. (2015). The Binding Interface between Human APOBEC3F and HIV-1 Vif Elucidated by Genetic and Computational Approaches. Cell Reports. 13(9). 1781–1788. 29 indexed citations
12.
Albin, John S., William L. Brown, & Reuben S. Harris. (2013). Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus. Virology. 450-451. 49–54. 22 indexed citations
13.
Bohn, Markus‐Frederik, Shivender M.D. Shandilya, John S. Albin, et al.. (2013). Crystal Structure of the DNA Cytosine Deaminase APOBEC3F: The Catalytically Active and HIV-1 Vif-Binding Domain. Structure. 21(6). 1042–1050. 83 indexed citations
14.
Albin, John S., John S. Anderson, Jeffrey R. Johnson, et al.. (2013). Dispersed Sites of HIV Vif-Dependent Polyubiquitination in the DNA Deaminase APOBEC3F. Journal of Molecular Biology. 425(7). 1172–1182. 20 indexed citations
15.
Albin, John S., Rebecca S. LaRue, William L. Brown, et al.. (2010). A Single Amino Acid in Human APOBEC3F Alters Susceptibility to HIV-1 Vif. Journal of Biological Chemistry. 285(52). 40785–40792. 44 indexed citations
16.
Refsland, Eric W., Mark D. Stenglein, Keisuke Shindo, et al.. (2010). Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Research. 38(13). 4274–4284. 293 indexed citations
17.
Albin, John S. & Reuben S. Harris. (2010). Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert Reviews in Molecular Medicine. 12. e4–e4. 154 indexed citations
18.
Albin, John S., Guylaine Haché, Judd F. Hultquist, William L. Brown, & Reuben S. Harris. (2010). Long-Term Restriction by APOBEC3F Selects Human Immunodeficiency Virus Type 1 Variants with Restored Vif Function. Journal of Virology. 84(19). 10209–10219. 42 indexed citations
19.
Wang, Han, et al.. (2008). Caenorhabditis elegansABCRNAi Transporters Interact Genetically Withrde-2andmut-7. Genetics. 178(2). 801–814. 11 indexed citations
20.
Haché, Guylaine, Keisuke Shindo, John S. Albin, & Reuben S. Harris. (2008). Evolution of HIV-1 Isolates that Use a Novel Vif-Independent Mechanism to Resist Restriction by Human APOBEC3G. Current Biology. 18(11). 819–824. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark T. Liddament Breakdown of academic impact, for papers by Phuong Thi Nguyen Sarkis Breakdown of academic impact, for papers by Matthieu Bertrand Breakdown of academic impact, for papers by Mariana Santa‐Marta Breakdown of academic impact, for papers by April J. Schumacher Breakdown of academic impact, for papers by Eric C. Logue Breakdown of academic impact, for papers by James D. Roser Breakdown of academic impact, for papers by Elina Erikson Breakdown of academic impact, for papers by Joy Lengyel Breakdown of academic impact, for papers by Loïc Dragin
Rankless by CCL
2026